Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Daily deal net: May 28, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
AbCellera accelerates with $105m
University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.
Pliant places IPO terms
Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.
Apple picks up Inductiv
Apple has bought Inductiv to integrate the latter's machine learning data cleanup expertise, based on Stanford, Wisconsin-Madison and Waterloo faculty innovations.
CFS fuses $84m with series A2
MIT's fusion energy spinout Commonwealth Fusion Systems secured the return of The Engine and Eni for a $84m series A2 round that followed a $115m series A last year.
ID Connect links up with Ilúm Health
UPMC's ID Connect has absorbed Merck & Co's Ilúm Health Solutions to boost its client base and services offering.
Inivata invokes $25m from NeoGenomics
CRUK and Cambridge precision cancer diagnostics spinout Inivata has secured $25m from NeoGenomics as part of a deal that includes an acquisition option.
Statespace locks in $15m
NYU-founded cognitive skills building software developer Statespace secured investors including Khosla Ventures to bring its overall funding to $19m.

News Continued

UA’s FreeFall Aerospace completes merger
UAVC-backed antenna technology spinout FreeFall Aerospace has merged with one of its clients in order to focus its efforts on 5G communications.
Daily deal net: May 26, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Truework verifies $30m
Truework, which provides software to run employment and income background checks, secured the return of Sequoia Capital and Khosla Ventures to bring its total to $45m.
Exscientia extrapolates $60m series C
Novo has led a $60m series C round for University of Dundee’s Exscientia that also attracted Evotec, Bristol-Myers Squibb, and GT Healthcare Capital.
Nautilus captures $76m
Stanford’s proteomic analysis spinout has lifted its funding haul beyond $100m with a round set to drive new hires and technology development.
Oxford Nanopore packs $98.1m
Oxford Nanopore has added $59.6m to its latest funding round to bring the round to $98.1m and its overall funding to nearly $692m.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg